CHAMPIONS ONCOLOGY, INC. (CSBR)

Every figure this model derived for CSBR, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-04-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 564,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-04-30
cash 4,872,000 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-04-30
current assets 19,219,000 AssetsCurrent 2026-04-30
current liabilities 19,922,000 LiabilitiesCurrent 2026-04-30
equity 3,939,000 StockholdersEquity 2026-04-30
ocf -4,472,000 NetCashProvidedByUsedInOperatingActivities 2026-04-30
revenue 9,317,000 SellingAndMarketingExpense 2026-04-30
sbc 1,237,000 ShareBasedCompensation 2026-04-30

The ratios

The figures themselves rather than their scores — what somebody looking up CSBR on one particular measure came for.

RatioValue
cash operating margin15.6
current ratio1.73
current ratio reported0.96
deferred revenue growth-42.83
dilution pct-3.05
fcf margin-54.05
growth cv0.68
operating margin-12.24
owner earnings margin-67.33
revenue growth23.49
revenue growth per share27.37
rule of 4011.25
sbc pct revenue13.28

What to be careful about

What this model itself distrusts about CSBR's figures. Written by the derivation as it ran, not added afterwards.